FDA approval for Yeztugo The U.S. FDA has recently approved Yeztugo (lenacapavir), a twice-a-year injectable medication by Gilead Sciences for the prevention of HIV in high-risk individuals. This long-acting drug… Continue Reading
Blogs
Glenmark Launches Zanubrutinib in India: New Hope in Blood Cancer Treatment
Glenmark Pharmaceuticals to Launch Zanubrutinib for Cancer Treatment in India June 19, 2025 | Mumbai: Glenmark Pharmaceuticals, a leading Indian multinational pharmaceutical company, announced on Monday its plans to launch… Continue Reading
Could Weight Loss Drugs Be the Answer to India’s Growing Obesity Crisis?
Mounjaro Enters India Eli Lilly, the American pharmaceutical giant, announced the launch of its diabetes and weight-loss treatment, Mounjaro (tirzepatide), in India. With approval from India’s Central Drugs Standard Control… Continue Reading
Medicine Prices Increasing from April 1: Patients to Pay More for Essential Drugs
NPPA Approves 1.7% Hike on Essential Drug Prices: What Patients Need to Know New Delhi, March 28, 2025 – Starting April 1, 2025, many of patients across India will face… Continue Reading
Rising Interest of International Patients for Cancer Treatment in India
Cancer is a devastating disease that is affecting millions of people globally. Moreover, it drains patients physically and financially. Recently, India has emerged as a hub for medical tourism and… Continue Reading